Research ArticleCystic Fibrosis

Potentiator ivacaftor abrogates pharmacological correction of ΔF508 CFTR in cystic fibrosis

See allHide authors and affiliations

Science Translational Medicine  23 Jul 2014:
Vol. 6, Issue 246, pp. 246ra96
DOI: 10.1126/scitranslmed.3008680

Log in to view full text

Log in through your institution

Log in through your institution

Navigate This Article